Search
Menu
Home
Sources
About
Contacts
Lesogaberan
Lesogaberan
was an
experimental drug
candidate
developed by
AstraZeneca
for the
treatment
of
gastroesophageal reflux disease
. As a
GABA
B
receptor agonist
, it has the same
mechanism of action
as
baclofen
, but is
anticipated
to have
fewer
of the
central nervous system
side effects
that
limit
the
clinical use
of baclofen for the treatment of
GERD
.
